News

Uveitic relapses primarily manifest as anterior uveitis, the authors said

At the ESCRS meeting, Sir Harold Ridley’s legacy was put on display in a pop-up museum installation

ARVN001 is indicated for the treatment of uveitic macular oedema and certain other ophthalmic indications

The incidence was comparable to that of daily wear soft contact lenses

OPUVIZ, previously known as the biosimilar candidate SB15, has been approved for the treatment of nAMD, DME and other retinal diseases

The positive opinion marks a key regulatory step towards the approval of FYB203, which will go by the trade names AHZANTIVE and Baiama in the European Union

The CRL comes in response to a supplemental New Drug Application for Izervay, a treatment for geographic atrophy secondary to age-related macular degeneration

Optical coherence tomography will be in all eye care services by October 2025

Assessing two devices in a real-world setting

The biosimilar to reference aflibercept (Eylea, Bayer AG) is indicated to treat retinal diseases including neovascular age-related macular degeneration

A coalition of eye health advocacy groups vocalised support for the legislation

HG202, by HuidaGene Therapeutics, is formulated for clinical use in treating neovascular age-related macular degeneration

New analysis brings disease progression and therapeutics into focus

Following oculoplastic surgery, patients who underwent aromatherapy had shorter stays in the post-anesthesia care unit

Collaboration and outside-the-box thinking present significant opportunities for science and industry

This year’s Barcelona meeting brought together award-winning research data and leaders in the retina field

This article by Liem Trinh, MD highlights his experiences with the AT ELANA® 841P hydrophobic trifocal IOL and the ARTEVO® 750 and ARTEVO® 850 microscopes from ZEISS. Dr. Trinh discusses the benefits of the trifocal design of the AT ELANA 841P IOL and its ability to provide spectacle independence at all distances after cataract surgery. He also shares his positive experiences with the ARTEVO 850 microscope, which offers improved surgical visualization with RGB LED illumination and 3D viewing on a high dynamic range monitor. Additionally, Dr. Trinh discusses the potential benefits of integrated intraoperative optical coherence tomography (OCT) and the redesigned CALLISTO eye user interface.

Two glaucoma specialists discuss pairing patients with the right procedures

Caffeine has been shown to temporarily increase intraocular pressure and reduce blood flow in critical ocular regions

Investigators from Bergen, Norway, and Cleveland, Ohio, collaborated on the predictive model

Patients underwent electropuncture, low-intensity laser stimulation of the ciliary muscle, combined therapy and optical-reflex treatment of accommodation

Moving on from medication “stacks” and the old-school reactive approach

The authors reported significant variability in DED-related symptoms, with higher prevalence rates among university students and administrative workers

New investment from Sanoptis will support Ikerian technology for large-scale, AI-enabled data management

During a conversation at the American Academy of Ophthalmology annual meeting in Chicago, T.Y. Alvin Liu, MD, discussed plans for the James P. Gills Jr, MD, & Heather Gills Artificial Intelligence Innovation Center at the Wilmer Eye Institute at Johns Hopkins Medicine.

Nathan Radcliffe, MD, shared insights from his presentation at the annual meeting of the American Academy of Ophthalmology entitled, "Early cataract extraction for angle closure glaucoma."

The company also announced it will seek a strategic partner to continue development of APX3330, an oral small-molecule inhibitor of Ref-1 for the treatment of non-proliferative diabetic retinopathy.

Dr. Arepalli discussed a course focused on ocular conditions related to pregnancy and postpartum care, presented at the American Academy of Ophthalmology (AAO) meeting.

Alexander Fein, MD, spoke with the Eye Care Network to share how to approach a patient presenting with transient vision loss, what this type of vision loss can mean, and what additional testing might be needed to determine the best plan for care.

Jennifer Loh, MD, shared insights from on her presentation at the American Academy of Ophthalmology meeting in Chicago on the effects of CSF-1, which is the lowest effective concentration of pilocarpine approved in the United States.